BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6713775)

  • 1. Isosorbide 5-mononitrate kinetics.
    Major RM; Taylor T; Chasseaud LF; Darragh A; Lambe RF
    Clin Pharmacol Ther; 1984 May; 35(5):653-9. PubMed ID: 6713775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
    Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
    Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
    Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
    Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and excretion of isosorbide dinitrate and isosorbide-2-mononitrate in dogs.
    Cayen MN; Hicks D; Karounis J; Dvornik D
    J Pharm Pharmacol; 1983 May; 35(5):312-6. PubMed ID: 6134800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosorbide 5-mononitrate pharmacokinetics in humans.
    Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
    Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
    Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
    Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fact of 14C-isosorbide 5-mononitrate in humans.
    Wood SG; John BA; Chasseaud LF; Major RM; Forrest ME; Bonn R; Darragh A; Lambe RF
    Arzneimittelforschung; 1984; 34(9):1031-5. PubMed ID: 6542370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.
    Taylor T; Chasseaud LF; Doyle E; Darragh A; O'Kelly DA; Fitzgerald D
    Biopharm Drug Dispos; 1980; 1(3):149-56. PubMed ID: 7448342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
    Straehl P; Galeazzi RL
    Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
    Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
    Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer aspects of the pharmacokinetics of organic nitrates.
    Chasseaud LF
    Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
    Laufen H; Aumann M; Leitold M
    Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
    Morrison RA; Fung HL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isosorbide 5-mononitrate pharmacokinetics.
    Chasseaud LF
    Cardiology; 1987; 74 Suppl 1():6-11. PubMed ID: 3300979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Bechtold H; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Jun; 33(6):747-56. PubMed ID: 6851405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
    Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
    Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.